Vilya
VerifiedDeveloping a novel class of drugs that precisely target the biology of disease.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$250m (Public information from Jun 2024)
Seattle Washington (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
* | $21.0m Valuation: $250m | Series A | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Vilya
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.